StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron cash

Cash and short-term investments held at the end of each period.

Geron's cash was $62.64M at Jun 30, 2026. For fiscal 2025 it was $77.56M, down 80.9% from the year before. Over ten years it grew 13.8% a year on average. The highest annual figure on record is $406.57M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$77.56M-80.9%
FY2024Dec 31, 2024$406.57M+21.8%
FY2023Dec 31, 2023$333.70M+93.2%
FY2022Dec 31, 2022$172.75M-6.0%
FY2021Dec 31, 2021$183.72M-6.4%
FY2020Dec 31, 2020$196.28M+40.9%
FY2019Dec 31, 2019$139.33M-14.7%
FY2018Dec 31, 2018$163.29M+72.5%
FY2017Dec 31, 2017$94.69M+624.0%
FY2016Dec 31, 2016$13.08M-38.5%
FY2015Dec 31, 2015$21.25M-50.4%
FY2014Dec 31, 2014$42.80M+229.5%
FY2013Dec 31, 2013$12.99M-41.1%
FY2012Dec 31, 2012$22.06M+37.0%
FY2011Dec 31, 2011$16.11M-65.0%
FY2010Dec 31, 2010$45.97M+32.9%
FY2009Dec 31, 2009$34.60M-68.4%
FY2008Dec 31, 2008$109.35M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$62.64M-19.4%
Q1 FY2026Mar 31, 2026$68.90M-17.7%
Q4 FY2025Dec 31, 2025$77.56M-80.9%
Q3 FY2025Sep 30, 2025$78.12M-77.0%
Q2 FY2025Jun 30, 2025$77.73M-78.6%
Q1 FY2025Mar 31, 2025$83.75M-81.1%
Q4 FY2024Dec 31, 2024$406.57M+21.8%
Q3 FY2024Sep 30, 2024$339.77M+8.4%
Q2 FY2024Jun 30, 2024$362.73M-2.3%
Q1 FY2024Mar 31, 2024$443.05M+16.4%
Q4 FY2023Dec 31, 2023$333.70M+93.2%
Q3 FY2023Sep 30, 2023$313.53M+61.0%
Q2 FY2023Jun 30, 2023$371.38M+69.4%
Q1 FY2023Mar 31, 2023$380.74M+128.4%
Q4 FY2022Dec 31, 2022$172.75M-6.0%
Q3 FY2022Sep 30, 2022$194.79M+10.6%
Q2 FY2022Jun 30, 2022$219.29M+10.6%
Q1 FY2022Mar 31, 2022$166.67M-21.0%
Q4 FY2021Dec 31, 2021$183.72M-6.4%
Q3 FY2021Sep 30, 2021$176.12M-22.6%
Q2 FY2021Jun 30, 2021$198.24M-9.4%
Q1 FY2021Mar 31, 2021$211.03M+59.7%
Q4 FY2020Dec 31, 2020$196.28M+40.9%
Q3 FY2020Sep 30, 2020$227.62M+64.2%
Q2 FY2020Jun 30, 2020$218.75M+43.5%
Q1 FY2020Mar 31, 2020$132.12M-13.1%
Q4 FY2019Dec 31, 2019$139.33M-14.7%
Q3 FY2019Sep 30, 2019$138.61M-16.7%
Q2 FY2019Jun 30, 2019$152.49M+697.2%
Q1 FY2019Mar 31, 2019$151.98M+1820.9%
Q4 FY2018Dec 31, 2018$163.29M+72.5%
Q3 FY2018Sep 30, 2018$166.35M+1579.6%
Q2 FY2018Jun 30, 2018$19.13M+189.5%
Q1 FY2018Mar 31, 2018$7.91M-47.7%
Q4 FY2017Dec 31, 2017$94.69M+624.0%
Q3 FY2017Sep 30, 2017$9.90M+68.3%
Q2 FY2017Jun 30, 2017$6.61M–
Q1 FY2017Mar 31, 2017$15.13M–
Q4 FY2016Dec 31, 2016$13.08M–
Q3 FY2016Sep 30, 2016$5.88M–

More Geron figures

See a number that looks wrong?